Lund, Sweden

Artur Schmidtchen

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Artur Schmidtchen: Innovator in Anti-Inflammatory and Anti-Coagulant Therapies

Introduction

Artur Schmidtchen is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biomedical research, particularly in the development of polypeptides with therapeutic applications. With a total of 6 patents, Schmidtchen's work focuses on innovative solutions for treating inflammation and blood coagulation disorders.

Latest Patents

Schmidtchen's latest patents include groundbreaking inventions such as Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity. This invention provides polypeptides that comprise or consist of an amino acid sequence derived from a naturally occurring protein that modulates blood coagulation. These polypeptides are designed for use in the treatment or prevention of inflammation and excessive coagulation of the blood. Related aspects of the invention include isolated polypeptides that exhibit anti-inflammatory activity, along with isolated nucleic acid molecules, vectors, and host cells for their production. Additionally, pharmaceutical compositions containing these polypeptides are also provided, along with methods for their use in treating inflammation and coagulation issues.

Another significant patent involves polypeptides derived from thrombin, which also target inflammation and excessive blood coagulation. This invention similarly includes isolated polypeptides, nucleic acid molecules, and pharmaceutical compositions aimed at addressing these medical challenges.

Career Highlights

Throughout his career, Schmidtchen has worked with various companies, including Dermagen AB and Pergamum AB. His experience in these organizations has allowed him to refine his expertise in the development of therapeutic polypeptides and their applications in medicine.

Collaborations

Some of Schmidtchen's notable coworkers include Martin Malmsten and Björn Walse. Their collaborative efforts have contributed to advancing research in the field of anti-inflammatory and anti-coagulant therapies.

Conclusion

Artur Schmidtchen's innovative work in the development of polypeptides for medical applications highlights his significant contributions to the field of biomedical research. His patents reflect a commitment to improving treatment options for inflammation and coagulation disorders, showcasing the impact of his inventions on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…